NOVA LEAP HEALTH CORP (NLH.CA) Fundamental Analysis & Valuation

TSX-V:NLH • CA66980G1090

Current stock price

0.36 CAD
+0.01 (+2.86%)
Last:

This NLH.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. NLH.CA Profitability Analysis

1.1 Basic Checks

  • In the past year NLH has reported negative net income.
  • In the past year NLH had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: NLH reported negative net income in multiple years.
  • In the past 5 years NLH always reported a positive cash flow from operatings.
NLH.CA Yearly Net Income VS EBIT VS OCF VS FCFNLH.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1M -1M 2M 3M

1.2 Ratios

  • NLH has a Return On Assets of -0.81%. This is in the lower half of the industry: NLH underperforms 61.54% of its industry peers.
  • With a Return On Equity value of -1.00%, NLH perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 4.26%, NLH is in line with its industry, outperforming 53.85% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for NLH is below the industry average of 6.93%.
  • The 3 year average ROIC (3.17%) for NLH is below the current ROIC(4.26%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.81%
ROE -1%
ROIC 4.26%
ROA(3y)0.1%
ROA(5y)0.68%
ROE(3y)0.25%
ROE(5y)1.16%
ROIC(3y)3.17%
ROIC(5y)N/A
NLH.CA Yearly ROA, ROE, ROICNLH.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

1.3 Margins

  • With a Operating Margin value of 3.52%, NLH perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
  • With a Gross Margin value of 39.67%, NLH perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
  • In the last couple of years the Gross Margin of NLH has grown nicely.
Industry RankSector Rank
OM 3.52%
PM (TTM) N/A
GM 39.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.9%
GM growth 5Y3.18%
NLH.CA Yearly Profit, Operating, Gross MarginsNLH.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. NLH.CA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NLH is destroying value.
  • Compared to 1 year ago, NLH has about the same amount of shares outstanding.
  • NLH has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for NLH is higher compared to a year ago.
NLH.CA Yearly Shares OutstandingNLH.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
NLH.CA Yearly Total Debt VS Total AssetsNLH.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

2.2 Solvency

  • An Altman-Z score of 4.50 indicates that NLH is not in any danger for bankruptcy at the moment.
  • NLH has a Altman-Z score of 4.50. This is amongst the best in the industry. NLH outperforms 92.31% of its industry peers.
  • NLH has a debt to FCF ratio of 1.88. This is a very positive value and a sign of high solvency as it would only need 1.88 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.88, NLH belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • NLH has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
  • NLH has a better Debt to Equity ratio (0.04) than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 1.88
Altman-Z 4.5
ROIC/WACC0.54
WACC7.89%
NLH.CA Yearly LT Debt VS Equity VS FCFNLH.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M 15M

2.3 Liquidity

  • A Current Ratio of 0.96 indicates that NLH may have some problems paying its short term obligations.
  • NLH has a Current ratio of 0.96. This is in the better half of the industry: NLH outperforms 61.54% of its industry peers.
  • A Quick Ratio of 0.96 indicates that NLH may have some problems paying its short term obligations.
  • The Quick ratio of NLH (0.96) is better than 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.96
NLH.CA Yearly Current Assets VS Current LiabilitesNLH.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. NLH.CA Growth Analysis

3.1 Past

  • The earnings per share for NLH have decreased strongly by -113.21% in the last year.
  • NLH shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.15%.
  • The Revenue has been growing by 12.70% on average over the past years. This is quite good.
EPS 1Y (TTM)-113.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.83%
Revenue 1Y (TTM)22.15%
Revenue growth 3Y3.72%
Revenue growth 5Y12.7%
Sales Q2Q%22.81%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NLH.CA Yearly Revenue VS EstimatesNLH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
NLH.CA Yearly EPS VS EstimatesNLH.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 0 0.01 0.02 0.03

More info and screens

Find the best growth stocksShow best growing peers

2

4. NLH.CA Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
NLH.CA Price Earnings VS Forward Price EarningsNLH.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • 76.92% of the companies in the same industry are more expensive than NLH, based on the Enterprise Value to EBITDA ratio.
  • NLH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. NLH is cheaper than 61.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.61
EV/EBITDA 12.47
NLH.CA Per share dataNLH.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NLH.CA Dividend Analysis

5.1 Amount

  • NLH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NLH.CA Fundamentals: All Metrics, Ratios and Statistics

NOVA LEAP HEALTH CORP

TSX-V:NLH (4/10/2026, 7:00:00 PM)

0.36

+0.01 (+2.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-05
Earnings (Next)05-07
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners18.98%
Ins Owner ChangeN/A
Market Cap31.43M
Revenue(TTM)31.47M
Net Income(TTM)-189.80K
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.72
P/FCF 14.61
P/OCF 14.61
P/B 1.19
P/tB 15.85
EV/EBITDA 12.47
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY6.84%
OCF(TTM)0.02
OCFY6.84%
SpS0.5
BVpS0.3
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.81%
ROE -1%
ROCE 5.6%
ROIC 4.26%
ROICexc 4.61%
ROICexgc 128.53%
OM 3.52%
PM (TTM) N/A
GM 39.67%
FCFM 4.95%
ROA(3y)0.1%
ROA(5y)0.68%
ROE(3y)0.25%
ROE(5y)1.16%
ROIC(3y)3.17%
ROIC(5y)N/A
ROICexc(3y)3.41%
ROICexc(5y)N/A
ROICexgc(3y)65.83%
ROICexgc(5y)N/A
ROCE(3y)4.17%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.9%
GM growth 5Y3.18%
F-Score5
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 1.88
Debt/EBITDA 0.37
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage 4.68
Cash Conversion 80.26%
Profit Quality N/A
Current Ratio 0.96
Quick Ratio 0.96
Altman-Z 4.5
F-Score5
WACC7.89%
ROIC/WACC0.54
Cap/Depr(3y)2.48%
Cap/Depr(5y)2.54%
Cap/Sales(3y)0.07%
Cap/Sales(5y)0.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-113.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.15%
Revenue growth 3Y3.72%
Revenue growth 5Y12.7%
Sales Q2Q%22.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y28.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y14.19%
FCF growth 3Y17.91%
FCF growth 5Y-12.33%
OCF growth 1Y12.13%
OCF growth 3Y15.1%
OCF growth 5Y-12.37%

NOVA LEAP HEALTH CORP / NLH.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NOVA LEAP HEALTH CORP (NLH.CA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to NLH.CA.


What is the valuation status of NOVA LEAP HEALTH CORP (NLH.CA) stock?

ChartMill assigns a valuation rating of 1 / 10 to NOVA LEAP HEALTH CORP (NLH.CA). This can be considered as Overvalued.


Can you provide the profitability details for NOVA LEAP HEALTH CORP?

NOVA LEAP HEALTH CORP (NLH.CA) has a profitability rating of 4 / 10.


What is the financial health of NOVA LEAP HEALTH CORP (NLH.CA) stock?

The financial health rating of NOVA LEAP HEALTH CORP (NLH.CA) is 5 / 10.